The Risks from Non-Human Estrogen Use

Evaluating Risk Factors: Non-Human Estrogen Use

Evaluating your likely current (and near future) state of health means taking into account the risk factors — such as non-human estrogen use — that affect you. Our medical diagnosis tool, The Analyst™, identifies major risk factors by asking the right questions.

Diagnose your symptoms now!

see your health summarized and in detail
learn what you should be doing right now
have a doctor review your case (optional)

If you indicate having used hormones, The Analyst™ will ask further questions including this one:

Have you used non-human estrogens (such as Premarin, Estrace, or Prempro)? In the past, it may have been referred to as HRT (Hormone Replacement Therapy).

Possible responses:

→ No / don't know
→ For under 5 years, but not any more
→ For 5 or more years, but not any more
→ Current use for under 5 years
→ Current use for 5 or more years

The Diagnostic Process

Based on your response to this question, which may indicate either discontinued non-human estrogen use or non-human estrogen use, The Analyst™ will use differential diagnosis to consider possibilities such as:

Breast Cancer

Recent findings from a landmark study, published in The New England Journal of Medicine in 1995 and involving 121,700 women, revealed startling effects from non-human estrogen use. It warned that women who used this type of estrogens to offset the symptoms of menopause also increased their chance of developing breast cancer by 30-40% by taking the hormone for more than five years. In women aged between 60 and 64, the risk of breast cancer rose to 70% after five years of use. Finally, the study concluded that women were 45% more likely to die from breast cancer than those who chose not to use them or used them for less than five years.

Endometrial Cancer

In 1975, The New England Journal of Medicine examined the rates of endometrial cancer for estrogen consumers, concluding that the risk was seven and a half times greater for estrogen users. Women who had used estrogen for seven years or longer were 14 times more likely to develop cancer. [Coney, Sandra, The Menopause Industry, Spinifex Press Pty Ltd., Australia, 1991, pp.164-5]

Gallbladder Disease

Taking non-human estrogens after menopause doubles the risk of gallbladder disease.

Magnesium Requirement

Progesterone Low or Estrogen Dominance

Vitamin B6 Requirement

Zinc Requirement

Concerned or curious about your health? Try The Analyst™